Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Seminars in Oncology|September 20, 2017
Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumorsThomas Enzler, Tito FojoCancer Letters|March 24, 2025
Pancreatic cancer precursor lesions - Can immunotherapy prevent progression into pancreatic ductal adenocarcinoma?Thomas Enzler, Timothy L FrankelExpert Opinion on Emerging Drugs|March 18, 2021
Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trialsJasmeet Kaur, Paramveer Singh, Thomas Enzler, et al.Frontiers in Oncology|March 11, 2026
Case Report: An exceptional response to a novel immunotherapy-based combination treatment for resected pancreatic ductal adenocarcinoma with recurrence to the abdominal wallThomas Enzler, Sara Tweedy, Isabella Holmes, et al.Pharmacology & Therapeutics|January 22, 2018
Combining chemotherapy with PD-1 blockade in NSCLCMatthen Mathew, Thomas Enzler, Catherine A Shu, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2009
MEKK1 binds HECT E3 ligase Itch by its amino-terminal RING motif to regulate Th2 cytokine gene expressionThomas Enzler, Xing Chang, Valeria Facchinetti, et al.Cancer Discovery|March 6, 2012
Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy modelThomas Enzler, Yasuyo Sano, Min-Kyung Choo, et al.Blood|May 8, 2007
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cellsThomas Enzler, Silke Gillessen, Michael Dougan, et al.The Journal of Experimental Medicine|May 7, 2003
Deficiencies of GM-CSF and interferon gamma link inflammation and cancerThomas Enzler, Silke Gillessen, John P Manis, et al.International Journal of Molecular Sciences|March 13, 2024
A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor LesionsThomas Enzler, Jiaqi Shi, Jake McGue, et al.Pageof 3